PIK3CA and neoplasm: Moreover, as expected, high activity of the PI3K/AKT pathway was described in the tumors of non-responders, but without difference of PD-L1 expression between responders and non-responders, suggesting that PTEN did not correlate with PD-L1 expression, at least in this tumor type.